AUSTIN, Texas--(BUSINESS WIRE)--Introgen Therapeutics, Inc. (NASDAQ:INGN) announced today that it will deliver a presentation at the 27th Annual Canaccord Adams Global Growth Conference in Boston. David G. Nance, president and CEO, is scheduled to present to leading institutional investment representatives on Thursday, August 9, 2007, at 11:00 a.m. ET, at the InterContinental Boston. Mr. Nance’s presentation will be webcast live and will be available at www.introgen.com.
